GlaxoSmithKline Pharmaceuticals
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Pharmaceuticals
 |
 |
Quarterly Results of GlaxoSmithKline Pharmaceuticals |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '08 | Dec '08 | Mar '09 | Jun '09 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 464.68 | 375.96 | 463.63 | 461.31 | 519.03 | |||||
| Other Income | 10.27 | 0.66 | 26.21 | 18.00 | -- | |||||
| Total Income | 474.95 | 376.62 | 489.84 | 479.31 | 519.03 | |||||
| Total Expenses | 288.27 | 264.77 | 295.26 | 293.87 | 323.74 | |||||
| Operating Profit | 176.41 | 111.19 | 168.37 | 167.44 | 195.29 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | 119.31 | 17.84 | -7.31 | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 186.68 | 111.85 | 194.58 | 185.44 | 195.29 | |||||
| Interest | -15.09 | -29.76 | -- | -19.39 | -16.84 | |||||
| PBDT | 201.77 | 260.92 | 212.42 | 197.52 | 212.13 | |||||
| Depreciation | 4.00 | 4.73 | 3.67 | 3.96 | 3.99 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 197.77 | 256.19 | 208.75 | 193.56 | 208.14 | |||||
| Tax | 65.80 | 47.72 | 65.48 | 69.21 | 67.06 | |||||
| Net Profit | 131.97 | 208.47 | 143.27 | 124.35 | 141.08 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 15.58 | 24.61 | 16.91 | 14.68 | 16.66 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 84.70 | 84.70 | 84.70 | 84.70 | 84.70 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore GlaxoSmithKline connections | ||||||||||
| ||||||||||
